| Aarti Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524348 |
NSE Symbol : AARTIDRUGS |
P/E(TTM) : 18.19 |
|
ISIN Demat : INE767A01016 |
Div & Yield% : 0.27 |
EPS(TTM) : 20.35 |
|
Book Value(₹) : 147.01 |
Market Cap(₹Cr) : 3,378.82 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 528.80 | 578.95 | 520.96 | 622.96 | 514.54 | 543.09 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 528.80 | 578.95 | 520.96 | 622.96 | 514.54 | 543.09 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.22 | 0.15 | 0.39 | 1.71 | 11.37 | 0.38 |
| Total Income | 530.02 | 579.10 | 521.35 | 624.67 | 525.91 | 543.47 |
| Total Expenditure | 486.49 | 503.76 | 457.01 | 534.31 | 454.29 | 483.55 |
| PBIDT | 43.53 | 75.34 | 64.34 | 90.36 | 71.62 | 59.92 |
| Interest | 6.95 | 6.01 | 6.82 | 7.48 | 7.57 | 7.17 |
| PBDT | 36.58 | 69.33 | 57.52 | 82.88 | 64.05 | 52.75 |
| Depreciation | 14.87 | 13.55 | 12.27 | 12.21 | 12.02 | 11.86 |
| Tax | -14.38 | 12.00 | -5.39 | 9.69 | 12.00 | 8.50 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.25 | 2.00 | 2.00 | -0.50 | 1.50 | 2.00 |
| Reported Profit After Tax | 33.84 | 41.78 | 48.64 | 61.48 | 38.53 | 30.39 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 33.84 | 41.78 | 48.64 | 61.48 | 38.53 | 30.39 |
| EPS (Unit Curr.) | 3.71 | 4.58 | 5.33 | 6.74 | 4.22 | 3.33 |
| EPS (Adj) (Unit Curr.) | 3.71 | 4.58 | 5.33 | 6.74 | 4.22 | 3.33 |
| Calculated EPS (Unit Curr.) | 3.71 | 4.58 | 5.33 | 6.74 | 4.22 | 3.33 |
| Calculated EPS (Adj) (Unit Curr.) | 3.71 | 4.58 | 5.33 | 6.74 | 4.22 | 3.33 |
| Calculated EPS (Ann.) (Unit Curr.) | 14.83 | 18.31 | 21.32 | 26.94 | 16.89 | 13.32 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 14.83 | 18.31 | 21.32 | 26.94 | 16.89 | 13.32 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 10.00 | 0.00 |
| Equity | 91.27 | 91.27 | 91.27 | 91.27 | 91.27 | 91.27 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,068.06 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.23 | 13.01 | 12.35 | 14.50 | 13.92 | 11.03 |
| PBDTM(%) | 6.92 | 11.98 | 11.04 | 13.30 | 12.45 | 9.71 |
| PATM(%) | 6.40 | 7.22 | 9.34 | 9.87 | 7.49 | 5.60 |